Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases
Sarcoma · 2013 · 2013 · 1-8
DOI: 10.1155/2013/798403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sarcoma, 2013. Verfasst von Jennifer Hung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tunnell Cancer Center, Beebe Medical Center, Rehoboth Beach, DE 19971, USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Angiosarcomas are aggressive tumors of vascular endothelial origin, occurring sporadically or in association with prior radiotherapy. We compared clinicopathologic and biologic features of sporadic angiosarcomas (SA) and radiation-associated angiosarcomas (RAA).
Methods
From a University of Michigan institutional database, 37 SA and 11 RAA were identified. Tissue microarrays were stained for p53, Ki-67, and hTERT. DNA was evaluated for TP53 and ATM mutations.
Results
Mean latency between radiotherapy and diagnosis of RAA was 11.9 years: 6.7 years for breast RAA versus 20.9 years for nonbreast RAA ( P = 0.148 ). Survival after diagnosis did not significantly differ between SA and RAA ( P = 0.590 ). Patients with nonbreast RAA had shorter overall survival than patients with breast RAA ( P = 0.03 ). The majority of SA (86.5%) and RAA (77.8%) were classified as high-grade sarcomas ( P = 0.609 ). RAA were more likely to have well-defined vasoformative areas (55.6% versus 27%, P = 0.127 ). Most breast SA were parenchymal in origin (80%), while most breast RAA were cutaneous in origin (80%). TMA analysis showed p53 overexpression in 25.7% of SA and 0% RAA, high Ki-67 in 35.3% of SA and 44.4% RAA, and hTERT expression in 100% of SA and RAA. TP53 mutations were detected in 13.5% of SA and 11.1% RAA. ATM mutations were not detected in either SA or RAA.
Conclusions
SA and RAA are similar in histology, immunohistochemical markers, and DNA mutation profiles and share similar prognosis. Breast RAA have a shorter latency period compared to nonbreast RAA and a significantly longer survival.
Autor:innen und Institutionen
- Tunnell Cancer Center, Beebe Medical Center, Rehoboth Beach, DE 19971, USA.
Zitieren
APA
Hung, J., Hiniker, S. M., Lucas, D. R., Griffith, K. A., McHugh, J. B., Meirovitz, A., Thomas, D. G., Chugh, R., & Herman, J. M. (2013). Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases. Sarcoma, 2013, 1-8. https://doi.org/10.1155/2013/798403
Vancouver
Hung J, Hiniker SM, Lucas DR, Griffith KA, McHugh JB, Meirovitz A, et al. Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases. Sarcoma. 2013;2013:1-8. doi:10.1155/2013/798403
BibTeX
@article{Hung2013,
author = {Hung, Jennifer and Hiniker, Susan M and Lucas, David R and Griffith, Kent A and McHugh, Jonathan B and Meirovitz, Amichay and Thomas, Dafydd G and Chugh, Rashmi and Herman, Joseph M},
title = {Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases},
journal = {Sarcoma},
year = {2013},
volume = {2013},
pages = {1--8},
doi = {10.1155/2013/798403}
}
EUVIMED